British Journal of Cancer Q1 Unclaimed

Nature Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

British Journal of Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 236. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 2700 €. The scope of the journal is focused on Clinical Cancer, Oncology, Radiotherapy, Chemotherapy. It has an SJR impact factor of 2,833 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,833.

British Journal of Cancer focuses its scope in these topics and keywords: cancer, breast, cell, study, lung, patients, expression, tumour, chemotherapy, human, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

2700 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

British Journal of Cancer

2,833

SJR Impact factor

236

H Index

457

Total Docs (Last Year)

1155

Total Docs (3 years)

19555

Total Refs

7208

Total Cites (3 years)

1049

Citable Docs (3 years)

5,94

Cites/Doc (2 years)

42,79

Ref/Doc

Aims and Scope


cancer, breast, cell, study, lung, patients, expression, tumour, chemotherapy, human, control, effects, risk, ovarian, colorectal, carcinoma, advanced, protein, case, tissue, growth, effect, Clinical Cancer, Oncology, Radiotherapy, Chemotherapy



Best articles by citations

Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease

View more

The taxanes: toxicity and quality of life considerations in advanced ovarian cancer

View more

Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy

View more

Interventions to promote cancer awareness and early presentation: systematic review

View more

Second primary breast cancer after Hodgkin's disease

View more

Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells

View more

Extensive experience of disease control with gefitinib and the role of prognostic markers

View more

Docetaxel: an alternative taxane in ovarian cancer

View more

Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037

View more

Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma

View more

Urinary tract infections and reduced risk of bladder cancer in Los Angeles

View more

Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group

View more
SHOW MORE ARTICLES

The National Awareness and Early Diagnosis Initiative in England: assembling the evidence

View more

Faecal bile acids and clostridia in the aetiology of colorectal cancer

View more

Gonorrhoea and male bladder cancer in a prospective study

View more

Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade

View more

RT Prepare: a radiation therapist-delivered intervention reduces psychological distress in women with breast cancer referred for radiotherapy

View more

Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study

View more

Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study

View more

Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions

View more

A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro

View more

A visual summary of the EUROCARE-4 results: a UK perspective

View more

Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma

View more

Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy

View more

Comments

No comments ... Be the first to comment!

FAQS